Fmoc-(S)-3-Amino-4-(2-bromo-phenyl)-butyric acid, 97%, 1g

ETHYL 6-BROMO-4-CHLORO-8-FLUOROQUINOLINE-3-CARBOXYLATE, 95%, 250mg

5-(5,5-dimethyl-1,3-dioxan-2-yl)-3',5'-dimethyl-4'-methoxyvalerophenone, 97.0%, 1g

1-(2-Bromo-4-methoxy-phenyl)-ethanone, 98%, 5g

1-Phenylpiperidin-4-amine, 95.0%, 1g

(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(2-(trifluoromethyl)phenyl)butanoic acid, 98%, 1g

5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalen-2-amine, 97.0%, 25g

1-(1,4-diazepan-1-yl)-3-phenylpropan-1-one, 95.0%, 2g

2-Amino-2-thiazoline hydrochloride, 99.0%, 5g

N-(2-ACETYLPHENYL)HEXANAMIDE, 95.0%, 250mg

2-Piperidinemethanol, 98.0%, 25g

[2,2'-Bipyridin]-4-amine, 97%, 100mg

Báscula de plataforma Serie DE Báscula de doble rango Serie DE-D, 1 / 2 g, 3000 / 6000 g, DE 6K1D